Free Trial
→ This is the “End of Tesla” as we know it… (From Brownstone Research) (Ad)tc pixel

EUROFINS SCIENT (OTCMKTS:ERFSF) Short Interest Update

Written by MarketBeat
Updated September 20, 2025
Eurofins Scient logo with Medical background

Key Points

  • Short interest in Eurofins Scient increased by 48.8% in August, rising from 65,100 shares to 96,900 shares, indicating a significant increase in investor skepticism.
  • The company's days-to-cover ratio is currently 33.4 days, suggesting it may take over a month for short sellers to cover their positions based on average trading volume.
  • Citigroup has reaffirmed a "neutral" rating on Eurofins Scient, while most analysts give the stock an average rating of "Hold."
  • Five stocks we like better than EUROFINS SCIENT.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 96,900 shares, a growth of 48.8% from the August 15th total of 65,100 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 2,900 shares, the days-to-cover ratio is currently 33.4 days. Based on an average daily volume of 2,900 shares, the days-to-cover ratio is currently 33.4 days. Currently, 0.1% of the shares of the company are sold short.

EUROFINS SCIENT Stock Performance

ERFSF stock traded up $1.40 on Friday, reaching $73.90. The company's stock had a trading volume of 909 shares, compared to its average volume of 1,281. EUROFINS SCIENT has a 52 week low of $46.36 and a 52 week high of $83.02. The firm has a fifty day moving average of $76.18 and a two-hundred day moving average of $67.01. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26.

Wall Street Analyst Weigh In

Separately, Citigroup reiterated a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold".

Check Out Our Latest Report on EUROFINS SCIENT

EUROFINS SCIENT Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Further Reading

Should You Invest $1,000 in EUROFINS SCIENT Right Now?

Before you consider EUROFINS SCIENT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.

While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover
Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.